Ji Yao Holding Group Co Ltd
Ji Yao Holding Group Co., Ltd. engages in the research and development, production, and wholesale of pharmaceutical products. It offers Chinese and western medicines. Ji Yao Holding Group Co., Ltd. was founded in 2000 and is headquartered in Meihekou, China.
Ji Yao Holding Group Co Ltd (300108) - Net Assets
Latest net assets as of March 2025: CN¥-1.57 Billion CNY
Based on the latest financial reports, Ji Yao Holding Group Co Ltd (300108) has net assets worth CN¥-1.57 Billion CNY as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.43 Billion) and total liabilities (CN¥3.00 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥-1.57 Billion |
| % of Total Assets | -109.72% |
| Annual Growth Rate | N/A |
| 5-Year Change | -5627.15% |
| 10-Year Change | -190.66% |
| Growth Volatility | 476.57 |
Ji Yao Holding Group Co Ltd - Net Assets Trend (2007–2024)
This chart illustrates how Ji Yao Holding Group Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ji Yao Holding Group Co Ltd (2007–2024)
The table below shows the annual net assets of Ji Yao Holding Group Co Ltd from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥-1.50 Billion | -86.26% |
| 2023-12-31 | CN¥-807.13 Million | -120.34% |
| 2022-12-31 | CN¥-366.31 Million | +18.73% |
| 2021-12-31 | CN¥-450.73 Million | -1757.10% |
| 2020-12-31 | CN¥27.20 Million | -93.38% |
| 2019-12-31 | CN¥410.57 Million | -81.74% |
| 2018-12-31 | CN¥2.25 Billion | +15.38% |
| 2017-12-31 | CN¥1.95 Billion | +7.92% |
| 2016-12-31 | CN¥1.81 Billion | +8.89% |
| 2015-12-31 | CN¥1.66 Billion | +9.10% |
| 2014-12-31 | CN¥1.52 Billion | +281.92% |
| 2013-12-31 | CN¥398.00 Million | +3.55% |
| 2012-12-31 | CN¥384.36 Million | +6.47% |
| 2011-12-31 | CN¥361.01 Million | +6.21% |
| 2010-12-31 | CN¥339.92 Million | +314.20% |
| 2009-12-31 | CN¥82.07 Million | +40.15% |
| 2008-12-31 | CN¥58.56 Million | +29.56% |
| 2007-12-31 | CN¥45.20 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ji Yao Holding Group Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 103683.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CN¥2.24 Billion | % |
| Total Equity | CN¥-776.52 Million | 100.00% |
Ji Yao Holding Group Co Ltd Competitors by Market Cap
The table below lists competitors of Ji Yao Holding Group Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ENGILITY HLDGS
F:EH2
|
$18.24 Million |
|
Onyx Gold Corp.
PINK:ONXGF
|
$18.25 Million |
|
Flanigans Enterprises Inc
NYSE MKT:BDL
|
$18.25 Million |
|
Ekiz Kimya Sanayi ve Ticaret AS
IS:EKIZ
|
$18.26 Million |
|
Vinyl Chemicals (India) Limited
NSE:VINYLINDIA
|
$18.23 Million |
|
Talphera Inc.
NASDAQ:TLPH
|
$18.23 Million |
|
Galaxia SM Inc
KO:011420
|
$18.22 Million |
|
Jindal Photo Limited
NSE:JINDALPHOT
|
$18.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ji Yao Holding Group Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -280,671,891 to -776,519,451, a change of -495,847,560.
- Net loss of 439,433,948 reduced equity.
- Dividend payments of 244 reduced retained earnings.
- Other comprehensive income decreased equity by 844,992,298.
- Other factors increased equity by 788,578,930.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-439.43 Million | -56.59% |
| Dividends Paid | CN¥244.23 | -0.0% |
| Other Comprehensive Income | CN¥-844.99 Million | -108.82% |
| Other Changes | CN¥788.58 Million | +101.55% |
| Total Change | CN¥- | % |
Book Value vs Market Value Analysis
This analysis compares Ji Yao Holding Group Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥2.93 | CN¥0.21 | x |
| 2018-12-31 | CN¥3.31 | CN¥0.21 | x |
| 2019-12-31 | CN¥0.57 | CN¥0.21 | x |
| 2020-12-31 | CN¥0.05 | CN¥0.21 | x |
| 2021-12-31 | CN¥-0.64 | CN¥0.21 | x |
| 2022-12-31 | CN¥0.12 | CN¥0.21 | x |
| 2023-12-31 | CN¥-0.42 | CN¥0.21 | x |
| 2024-12-31 | CN¥-1.17 | CN¥0.21 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ji Yao Holding Group Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -131.83%
- • Asset Turnover: 0.23x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-105.00%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 23.39% | 20.42% | 0.94x | 1.22x | CN¥6.05 Million |
| 2008 | 22.82% | 21.69% | 0.80x | 1.31x | CN¥7.51 Million |
| 2009 | 28.65% | 29.92% | 0.75x | 1.28x | CN¥15.30 Million |
| 2010 | 7.17% | 21.64% | 0.33x | 1.01x | CN¥-9.61 Million |
| 2011 | 7.57% | 21.59% | 0.33x | 1.06x | CN¥-8.77 Million |
| 2012 | 7.83% | 18.83% | 0.40x | 1.04x | CN¥-8.33 Million |
| 2013 | 6.82% | 16.48% | 0.35x | 1.17x | CN¥-12.64 Million |
| 2014 | 3.78% | 16.57% | 0.16x | 1.44x | CN¥-93.39 Million |
| 2015 | 8.29% | 20.35% | 0.29x | 1.42x | CN¥-28.02 Million |
| 2016 | 10.47% | 24.96% | 0.29x | 1.43x | CN¥8.31 Million |
| 2017 | 10.39% | 28.91% | 0.22x | 1.62x | CN¥7.59 Million |
| 2018 | 9.81% | 22.99% | 0.19x | 2.20x | CN¥-4.12 Million |
| 2019 | -469.89% | -166.24% | 0.33x | 8.59x | CN¥-1.81 Billion |
| 2020 | -1208.40% | -58.64% | 0.24x | 87.05x | CN¥-383.45 Million |
| 2021 | 0.00% | -65.91% | 0.28x | 0.00x | CN¥-408.96 Million |
| 2022 | -358.76% | -56.39% | 0.22x | 28.91x | CN¥-283.42 Million |
| 2023 | 0.00% | -100.93% | 0.18x | 0.00x | CN¥-321.24 Million |
| 2024 | 0.00% | -131.83% | 0.23x | 0.00x | CN¥-361.78 Million |
Industry Comparison
This section compares Ji Yao Holding Group Co Ltd's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $2,320,145,022
- Average return on equity (ROE) among peers: 10.16%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ji Yao Holding Group Co Ltd (300108) | CN¥-1.57 Billion | 23.39% | N/A | $18.23 Million |
| Cachet Pharmaceutical Co Ltd (002462) | $4.92 Billion | 13.40% | 1.65x | $437.62 Million |
| Yunnan Hongxiang Yixintang (002727) | $497.43 Million | 20.70% | 1.22x | $545.21 Million |
| Luyan Pharma Co Ltd (002788) | $746.00 Million | 15.21% | 3.60x | $450.11 Million |
| Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. (300937) | $856.04 Million | 6.95% | 0.97x | $170.91 Million |
| ShuYu Civilian Pharmacy Corp. Ltd. (301017) | $2.27 Billion | 10.12% | 2.47x | $188.58 Million |
| Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) | $1.78 Billion | 1.93% | 1.96x | $174.48 Million |
| Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) | $1.98 Billion | 5.80% | 1.33x | $323.73 Million |
| Shanghai No1 Pharmacy Co Ltd (600833) | $736.00 Million | 6.25% | 0.61x | $180.65 Million |
| Laobaixing Pharmacy (603883) | $7.10 Billion | 11.06% | 2.01x | $739.96 Million |